XML 46 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity and Weighted Average Exercise Prices
The following table is a summary of the Company’s stock option activity and weighted average exercise prices for the three months ended March 31, 2026:
Stock Option ActivityWeighted Average Remaining Contractual Term
(In years)
Aggregate Intrinsic Value
(In thousands)
Options
(In thousands)
Weighted
Average
Exercise Price
Balance outstanding at December 31, 2025178 $184.30 5.92$— 
Granted— — 
Exercised— — 
Cancelled or expired(2)461.55 
Balance outstanding at March 31, 2026176 180.47 5.74— 
Options vested and expected to vest 100 306.10 3.91— 
Options exercisable at March 31, 202682 $368.37 2.73$— 
The total fair value of stock options exercised during the three months ended March 31, 2026 and 2025 was immaterial.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table is a summary of the Company’s RSU and PRSU activity and weighted average grant date fair value for the three months ended March 31, 2026:
Number of SharesWeighted Average Grant Date Fair ValueAggregate Fair Value
(In thousands)(Per share)(In thousands)
Balance outstanding at December 31, 2025783 $15.45 $3,028 
Awarded44 3.76 
Released(62)31.36 
Forfeited(14)25.37 
Non-vested and outstanding at March 31, 2026751 13.30 1,914 
Expected to vest 628 $13.51 $1,602 
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
Total stock-based compensation costs included in the condensed consolidated statements of operations for the three months ended March 31, 2026 and 2025 are as follows:

Three Months Ended March 31,
20262025
(In thousands)
Cost of revenue $81 $186 
Sales and marketing 507 1,378 
General and administrative 1,153 1,773 
Product development 521 1,372 
Total$2,262 $4,709